Repetitive Immune-Mediated Noninfectious Endocarditis Necessitating 5 Mitral Valve Replacements
| Autor: | Maarten J. Cramer, Leo Koenderman, Steven A Muller, Helen L. Leavis, Karim Taha, Willem J.L. Suyker, Steven A. J. Chamuleau |
|---|---|
| Přispěvatelé: | Cardiology, ACS - Atherosclerosis & ischemic syndromes, ACS - Heart failure & arrhythmias |
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
TIA
transient ischemic attack medicine.medical_specialty medicine.medical_treatment Case Report MV mitral valve Immune system Clinical Case CTD connective tissue disease Internal medicine Mitral valve medicine Endocarditis Anakinra MVR mitral valve replacement business.industry Mitral valve replacement autoimmune TEE transesophageal echocardiography medicine.disease mitral valve replacement IVIG intravenous immunoglobulin repetitive medicine.anatomical_structure endocarditis Cardiology Cardiology and Cardiovascular Medicine business Dacron polyethylene terephtelate medicine.drug |
| Zdroj: | JACC: Case Reports, 3(13), 1483-1488. Elsevier Inc. JACC Case Reports Muller, S A, Leavis, H L, Taha, K, Koenderman, L, Chamuleau, S A J, Suyker, W J L & Cramer, M J 2021, ' Repetitive Immune-Mediated Noninfectious Endocarditis Necessitating 5 Mitral Valve Replacements ', JACC: Case Reports, vol. 3, no. 13, pp. 1483-1488 . https://doi.org/10.1016/j.jaccas.2021.07.034 |
| ISSN: | 2666-0849 |
| Popis: | We present a young patient who had to undergo 5 mitral valve replacements (MVR) because of a repetitive immune-mediated noninfectious endocarditis. The patient was treated with multiple anti-inflammatory drugs and high-dose prednisone. After the fifth MVR, the patient remained in stable condition using Anakinra after 22 months of follow-up. (Level of Difficulty: Advanced.) Central Illustration |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|